| # | Drug | Count |
|---|---|---|
| 0 | AMIODARONE HYDROCHLORIDE | 28 |
| 1 | BENDAMUSTINE HYDROCHLORIDE | 11 |
| 2 | SODIUM CHLORIDE | 11 |
| 3 | ACETAMINOPHEN | 10 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 9 |
| 5 | IRON SUCROSE | 9 |
| 6 | SODIUM CHLORIDE TABLET | 9 |
| 7 | SODIUM CHLORIDE TABLETS | 9 |
| 8 | ACETAMINOPHEN 500MG | 7 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEROPENEM-VABORBACTAM | 1 | 0.0200 |
| 1 | HEMIN | 4 | 0.0067 |
| 2 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 3 | BELINOSTAT | 1 | 0.0028 |
| 4 | CLEVIDIPINE | 1 | 0.0027 |
| 5 | AMIODARONE HYDROCHLORIDE | 28 | 0.0025 |
| 6 | OMADACYCLINE | 4 | 0.0023 |
| 7 | CEFTOLOZANE AND TAZOBACTAM | 2 | 0.0020 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 11 | 0.0013 |
| 9 | IRON SUCROSE | 9 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Osmotic Laxative [EPC] | 15 |
| 1 | Corticosteroid [EPC] | 13 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 3 | Parenteral Iron Replacement [EPC] | 9 |
| 4 | Loop Diuretic [EPC] | 8 |
| 5 | Fluoroquinolone Antibacterial [EPC] | 7 |
| 6 | Proton Pump Inhibitor [EPC] | 7 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 6 |
| 8 | Human Immunoglobulin G [EPC] | 6 |
| 9 | Potassium Salt [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parenteral Iron Replacement [EPC] | 9 | 0.0007 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |
| 3 | Tetracycline-class Antibacterial [EPC] | 4 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 7 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 9 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |